Target intelligence / Profile preview

Actin gamma 1 pseudogene 25 (ACTG1P25)

Target: ACTG1P25
Molecular classification: Other (Pseudogene)

Overview

Actin gamma 1 pseudogene 25 (ACTG1P25, also known as AGPG) is an annotated pseudogene in the human genome, located on chromosome 1 (genomic coordinates chr1:202861713-202875241, hg38). As a pseudogene, ACTG1P25 does not produce a functional protein and currently has no known biological role, disease association, or relevance as a therapeutic target. Pseudogenes are typically defined as nonfunctional segments of DNA that resemble functional genes, often resulting from gene duplication or retrotransposition events, and may be used in gene regulation or evolutionary studies but not as direct pharmaceutical targets.

Other names: AGPG

Beyond the preview

Go deeper on Actin gamma 1 pseudogene 25 (ACTG1P25).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Actin gamma 1 pseudogene 25 (ACTG1P25).

Explore the full profile